“Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomized, Placebo-Controlled Studies”. 2020. SKIN The Journal of Cutaneous Medicine 4 (5): s46. https://doi.org/10.25251/skin.4.supp.46.